The biosynthesis of anticoagulant heparan sulfate by the heparan sulfate 3-O-sulfotransferase isoform 5

Biochimica et Biophysica Acta - General Subjects

Volumn 1671, Issue 1-3, 2004, Pages 34-43

  Duncan, Michael B ^a   Chen, Jinghua ^a   Krise, Jeffrey P ^a   Liu, Jian ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

3OST; 3OST5 CHO; A CHO cell that stably expresses 3 OST 5; Anticoagulation; Antithrombin; AT; Blood coagulation; Chinese hamster ovary; CHO; Heparan sulfate; Heparan sulfate 3 O sulfotransferase; Heparan sulfate sulfotransferase; HS

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN; DISACCHARIDE; HEPARAN SULFATE; HEPARAN SULFATE 3 O SULFOTRANSFERASE 5; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOSYNTHESIS; BLOOD CLOTTING; CELL SURFACE; CHINESE HAMSTER; CONTROLLED STUDY; FEMALE; NONHUMAN; NORTHERN BLOTTING; OVARY CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANTICOAGULANTS; ANTITHROMBINS; CHO CELLS; CRICETINAE; DISACCHARIDES; ELECTROPHORESIS; FACTOR XA; HEPARITIN SULFATE; HUMANS; ISOENZYMES; PROTEIN BINDING; SULFOTRANSFERASES;

CRICETINAE; CRICETULUS GRISEUS;

EID: 1542298280     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2003.12.010     Document Type: Article

References (31)

1. Esko J.D., Selleck S.B. Order out of chaos: assembly of ligand binding sites in heparan sulfate. Ann. Rev. Biochem. 71:2002;435-471.
2. Linhardt R.J. Claude S. Hudson Award address in carbohydrate chemistry. Heparin: structure and activity. J. Med. Chem. 46:2003;2551-2564.
3. Bernfield M., Gotte M., Park P.W., Reizes O., Fitzgerald M.L., Lincecum J., Zako M. Functions of cell surface heparan sulfate proteoglycans. Ann. Rev. Biochem. 68:1999;729-777.
4. Liu J., Thorp S.C. Heparan sulfate and the roles in assisting viral infections. Med. Res. Rev. 22:2002;1-25.
5. Edge A.S.B., Spiro R.G. A specific structural alteration in the heparan sulphate of human glomerular basement membrane in diabetes. Diabetologia. 43:2000;1056-1059.
6. Sasisekharan R., Shriver Z., Venkataraman G., Narayanasami U. Roles of heparin-sulphate glycosaminoglycans in cancer. Nat. Rev., Cancer. 2:2002;521-528.
7. Miyamoto K., Asada K., Fukutomi T., Okochi E., Yagi Y., Hasegawa T., Asahara T., Sugimura T., Ushijima T. Methylation-associated silencing of heparan sulfate D-glucosaminyl 3-O-sulfotransferase-2 (3-OST-2) in human breast, colon, lung and pancreatic cancers. Oncogene. 22:2003;274-280.
8. Conrad H.E. Heparin-Binding Proteins. 1998;Academic Press, San Diego, CA.
9. Rosenberg R.D., Showrak N.W., Liu J., Schwartz J.J., Zhang L. Heparan sulfate proteoglycans of the cardiovascular system: specific structures emerge but how is synthesis regulated? J. Clin. Invest. 99:1997;2062-2070.
10. Rosenberg R.D., Oosta G.M., Jordan R.E., Gardner W.T. The interaction of heparin with thrombin and antithrombin. Biochem. Biophys. Res. Commun. 96:1980;1200-1208.
11. Jin L., Abrahams P., Skinner R., Petitou M., Pike R.N., Carrell R.W. The anticoagulant activation of antithrombin by heparin. Proc. Natl. Acad. Sci. 94:1997;14683-14688.
12. Desai U.R., Petitou M., Bjork I., Olson S.T. Mechanism of heparin activation of antithrombin. Role of individual residues of the pentasaccharide activating sequences in the recognition of native and active states of antithrombin. J. Biol. Chem. 273:1998;7478-7487.
13. Atha D.H., Lormeau J.-C., Petitou M., Rosenberg R.D., Choay J. Contribution of monosaccharide residues in heparin binding to antithrombin III. Biochemistry. 24:1985;6723-6729.
14. Liu J., Shworak N.W., Fritze L.M.S., Edelberg J.M., Rosenberg R.D. Purification of heparan sulfate D-glucosaminyl 3-O-sulfotransferase. J. Biol. Chem. 271:1996;27072-27082.
15. Zhang L., Beeler D.L., Lawrence R., Lech M., Liu J., Davis J.C., Shriver Z., Sasisekharan R., Rosenberg R.D. 6-O-Sulfotransferase-1 represents a critical enzyme in the anticoagulant heparan sulfate biosynthetic pathway. J. Biol. Chem. 276:2001;42311-42321.
16. HajMohammadi S., Enjyoji K., Princivalle M., Christi P., Lech M., Beeler D.L., Rayburn H., Schwartz J.J., Barzegar S., de Agostini A.I., Post M.J., Rosenberg R.D., Shworak N.W. Normal levels of anticoagulant heparan sulfate are not essential for normal hemostasis. J. Clin. Invest. 111:2003;989-999.
17. Xia G., Chen J., Tiwari V., Ju W., Li J.-P., Malmström A., Shukla D., Liu J. Heparan sulfate 3-O-sulfotransferase isoform 5 generates both an antithrombin-binding site and an entry receptor for herpes simplex virus, type 1. J. Biol. Chem. 277:2002;37912-37919.
18. Chen J., Duncan M.B., Carrick K., Pope M., Liu J. Biosynthesis of 3-O-sulfated heparan sulfate: unique substrate specificity of heparan sulfate 3-O-sulfotransferase isoform 5. Glycobiology. 13:2003;785-794.
19. Mochizuki H., Yoshida K., Gotoh M., Sugioka S., Kikuchi N., Kwon Y.-D., Tawada A., Maeyama K., Inaba N., Hiruma T., Kimata K., Narimatsu H. Characterization of a heparan sulfate 3-O-sulfotransferase-5 an enzyme synthesizing a tetrasulfated disaccharide. J. Biol. Chem. 278:2003;26780-26787.
20. Shively J.E., Conrad H.E. Formation of anhydrosugars in the chemical depolymerization of heparin. Biochemistry. 15:1976;3932-3942.
21. Liu J., Shworak N.W., Sinay P., Schwartz J.J., Zhang L., Fritze L.M.S., Rosenberg R.D. Expression of heparan sulfate D-glucosaminyl 3-O- sulfotransferase isoforms reveals novel substrate specificities. J. Biol. Chem. 274:1999;5185-5192.
22. Lee M.K., Lander A.D. Analysis affinity and structural selectivity in the binding of proteins to glycosaminoglycans: development of a sensitive electrophoretic approach. Proc. Natl. Acad. Sci. U. S. A. 88:1991;2768-2772.
23. Liu J., Shriver Z., Pope R.M., Thorp S.C., Duncan M.B., Copeland R.J., Raska C.S., Yoshida K., Eisenberg R.J., Cohen G., Linhardt R.J., Sasisekharan R. Characterization of a heparan sulfate octasaccharide that binds to herpes simplex viral type 1 glycoprotein D. J. Biol. Chem. 277:2002;33456-33467.
24. Zhang L., Schwartz J.J., Miller J., Liu J., Fritze L.M.S., Shworak N.W., Rosenberg R.D. The retinoic acid and cAMP-dependent up-regulation of 3-O-sulfotransferase-1 leads to a dramatic augmentation of anticoagulantly active heparan sulfate biosynthesis in F9 embryonal carcinoma cells. J. Biol. Chem. 273:1998;27998-28003.
25. Bjornsson S. Simultaneous preparation and quantitation of proteoglycans by precipitation with alcian blue. Anal. Biochem. 210:1993;282-291.
26. Zhang L., Lawrence R., Schwartz J.J., Bai X., Wei G., Esko J.D., Rosenberg R.D. The effect of precursor structures on the action of glucosaminyl 3-O-sulfotransferase-1 and the biosynthesis of anticoagulant heparan sulfate. J. Biol. Chem. 276:2001;28806-28813.
27. Shukla D., Liu J., Blaiklock P., Shworak N.W., Bai X., Esko J.D., Cohen G.H., Eisenberg R.J., Rosenberg R.D., Spear P.G. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell. 99:1999;13-22.
28. Shworak N.W., Liu J., Fritze L.M.S., Schwartz J.J., Zhang L., Logeart D., Rosenberg R.D. Molecular cloning and expression of mouse and human cDNAs encoding heparan sulfate D-glucosaminyl 3-O-sulfotransferase. J. Biol. Chem. 272:1997;28008-28019.
29. Liu J., Rosenberg R.D. Taniguchi N., Fukuda M. Handbook of Glycosyltransferases and their Related Genes. 2002;475-483 Springer-Verlag, Tokyo.
30. McKeehan W.L., Wu X., Kan M. Requirement for anticoagulant heparan sulfate in the fibroblast growth factor receptor complex. J. Biol. Chem. 274:1999;21511-21514.
31. Ye S., Luo Y., Lu W., Jones R.B., Linhardt R.J., Capila I., Toida T., Kan M., Pelletier H., McKeehan W.L. Structural basis for interaction of FGF-1, FGF-2, and FGF-7 with different heparan sulfate motifs. Biochemistry. 40:2001;14429-14439.